References

[1]

  • 3. Josephs KA, Duffy JR, Strand EA, Whitwell JL, Layton KF, Parisi JE, et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain. 2006;129(Pt 6):1385-98.
  • 4. Wilson SM, Ogar JM, Laluz V, Growdon M, Jang J, Glenn S, et al. Automated MRI-based classification of primary progressive aphasia variants. Neuroimage. 2009;47(4):1558-67.
  • 5. Grossman M. Primary progressive aphasia: clinicopathological correlations. Neurology. 2010;6:88-97.
  • 6. Mesulam M, Wicklund A, Johnson N, Rogalski E, Leger GC, Rademaker A, et al. Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol. 2008;63:709-19.
  • 7. Leyton CE, Villemagne VL, Savage S, Pike KE, Ballard KJ, Piguet O, et al. Subtypes of progressive aphasia: application of the International Consensus Criteria and validation using P-amyloid imaging. Brain. 2011;134(Pt 10):3030-43.
  • 8. Gorno-Tempini ML, Dronkers NF, Rankin KP, Ogar JM, Phengrasamy L, Rosen HJ, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol. 2004;55(3):335-46.
  • 9. Rabinovici GD, Jagust WJ, Furst AJ, Ogar JM, Racine CA, Mormino EC, et al. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol. 2008;64(4):388-401.
  • 10. Sajjadi SA, Patterson K, Arnold RJ, Watson PC, Nestor PJ. Primary progressive aphasia: a tale of two syndromes and the rest. Neurology. 2012;78(21):1670-7.
  • 11. Sajjadi SA, Patterson K, Nestor PJ. Logopenic, mixed, or Alzheimer-related aphasia? Neurology. 2014;82(13):1127-31.
  • 12. Maruta C, Pereira T, Madeira SC, De Mendonfa A, Guerreiro M. Classification of primary progressive aphasia: do unsupervised data mining methods support a logopenic variant? Amyotroph Lateral Scler Front Degener. 2015;16(3-4):147-59.
  • 13. Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(Pt 9):2456-77.
  • 14. Weintraub S, Rubin NP, Mesulam M-M. Primary progressive aphasia: longitudinal course, neuropsychological profile, and language features. Arch Neurol. 1990;47(12):1329-35.
  • 15. Banks SJ, Weintraub S. Neuropsychiatric symptoms in behavioral variant frontotemporal dementia and primary progressive aphasia. J Geriatr Psychiatry Neurol. 2008;21(2):133-41.
  • 16. Rohrer JD, Warren JD. Phenomenology and anatomy of abnormal behaviours in primary progressive aphasia. J Neurol Sci. 2010;293(1-2):35-8.
  • 17. Rosen HJ, Allison SC, Ogar JM, Amici S, Rose K, Dronkers N, et al. Behavioral features in semantic dementia vs other forms of progressive aphasias. Neurology. 2006;67(10):1752-6.
  • 18. Fatemi Y, Boeve BF, Duffy J, Petersen RC, Knopman DS, Cejka V, et al. Neuropsychiatric aspects of primary progressive aphasia. J Neuropsychiatry Clin Neurosci. 2011;23(2):168-72.
  • 19. Kertesz A, Davidson W, Munoz DG. Clinical and pathological overlap between frontotemporal dementia, primary progressive aphasia and corticobasal degeneration: the pick complex. Dement Geriatr Cogn Disord. 1999;10 Suppl 1:46-9.
  • 20. Marczinski CA, Davidson W, Kertesz A. A longitudinal study of behavior in frontotemporal dementia and primary progressive aphasia. Cogn Behav Neurol. 2004;17(4):185-90.
  • 21. Medina J, Weintraub S. Depression in primary progressive aphasia. J Geriatr Psychiatry Neurol. 2007;20(3):153-60.
  • 22. Singh TD, Duffy JR, Strand EA, Machulda MM, Whitwell JL, Josephs KA. Neuropsychiatric symptoms in primary progressive aphasia and apraxia of speech. Dement Geriatr Cogn Disord. 2015;39(3-4):228-38.
  • 23. Banks SJ, Weintraub S. Cognitive deficits and reduced insight in primary progressive aphasia. Am J Alzheimers Dis Other Demen. 2008;23(4):363-71.
  • 24. Blessed G, Tomlison BE, Roth M. The association between quantitative measures of dementia and of senile changes in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968;114(512):797-811.
  • 25. Liu W, Miller BL, Kramer JH, Rankin K, Wyss-Coray C, Gearhart R, et al. Behavioral disorders in the frontal and temporal variants of frontotemporal dementia. Neurology. 2004;62(5):742-8.
  • 26. Snowden JS, Bathgate D, Varma A, Blackshaw A, Gibbons ZC, Neary D. Distinct behavioural profiles in frontotemporal dementia and semantic dementia. J Neurol Neurosurg Psychiatry. 2001;70(3):323-32.
  • 27. Lu PH, Mendez MF, Lee GJ, Leow AD, Lee H-W, Shapira J, et al. Patterns of brain atrophy in clinical variants of frontotemporal lobar degeneration. Dement Geriatr Cogn Disord. 2013;35(1-2):34-50.
  • 28. Hodges JR, Patterson K, Oxbury S, Funnell E. Semantic dementia: progressive fluent aphasia with temporal lobe atrophy. Brain. 1992;115:1783-806.
  • 29. Kamminga J, Kumfor F, Burrell JR, Piguet O, Hodges JR, Irish M. Differentiating between right-lateralised semantic dementia and behavioural-variant frontotemporal dementia: an examination of clinical characteristics and emotion processing. J Neurol Neurosurg Psychiatry. 2015;86(10):1082-8.
  • 30. Bozeat S, Gregory CA, Ralph MA, Hodges JR. Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer’s disease? J Neurol Neurosurg Psychiatry. 2000;69:178-86.
  • 31. Sabbe T, Vandenbulcke M. Obsessive-compulsive behaviour in two patients with right temporal variant frontotemporal dementia. Tijdschr Psychiatr. 2014;56(10):685-8.
  • 32. Forbes CE, Grafman J. The role of the human prefrontal cortex in social cognition and moral judgment. Annu Rev Neurosci. 2010;33:299-324.
  • 33. Duval C, Bejanin A, Piolino P, Laisney M, de La Sayette V, Belliard S, et al. Theory of mind impairments in patients with semantic dementia. Brain. 2012;135(Pt 1):228-41.
  • 34. Savage SA, Piguet O, Hodges JR. “Knowing What You Don’t Know”: language insight in semantic dementia. J Alzheimers Dis. 2015;26.
  • 35. Rohrer JD, Rossor MN, Warren JD. Alzheimer’s pathology in primary progressive aphasia. Neurobiol Aging. 2012;33(4):744-52.
  • 36. Lyketsos CG, Carrillo MC, Ryan JM, Khachaturian AS, Trzepacz P, Amatniek J, et al. Neuropsychiatric symptoms in Alzheimer’s disease. Alzheimers Dement. 2011;7(5):532-9.
  • 37. Marra C, Quaranta D, Zinno M, Misciagna S, Bizzarro A, Masullo C, et al. Clusters of cognitive and behavioral disorders clearly distinguish primary progressive aphasia from frontal lobe dementia, and Alzheimer’s disease. Dement Geriatr Cogn Disord. 2007;24(5):317-26.
  • 38. Duffy JR, Strand EA, Clark H, Machulda M, Whitwell JL, Josephs KA. Primary progressive apraxia of speech: clinical features and acoustic and neurologic correlates. Am J Speech Lang Pathol. 2015;24(2):88-100.
  • 39. Duffy JR, Strand EA, Josephs KA. Motor speech disorders associated with primary progressive aphasia. Aphasiology. 2014;28(8-9):1004-17.
  • 40. Josephs KA, Duffy JR, Strand EA, Machulda MM, Senjem ML, Master AV, et al. Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech. Brain. 2012;135(Pt 5):1522-36.
  • 41. Rogalski E, Cobia D, Harrison TM, Wieneke C, Weintraub S, Mesulam M-M. Progression of language decline and cortical atrophy in subtypes of primary progressive aphasia. Neurology. 2011;76(21):1804-10.
  • 42. Perry RJ, Graham A, Williams G, Rosen H, Erzinflioglu S, Weiner M, et al. Patterns of frontal lobe atrophy in frontotemporal dementia: a volumetric MRI study. Dement Geriatr Cogn Disord. 2006;22(4):278-87.
  • 43. Grossman M. The non-fluent/agrammatic variant of primary progressive aphasia. Lancet Neurol. 2012;11(6):545-55.
  • 44. Sorbi S, Hort J, Erkinjuntti T, Fladby T, Gainotti G, Gurvit H, et al. EFNS-ENS guidelines on the diagnosis and management of disorders associated with dementia. Eur J Neurol. 2012;19(9):1159-79.
  • 45. Modirrousta M, Price BH, Dickerson BC. Neuropsychiatric symptoms in primary progressive aphasia: phenomenology, pathophysiology, and approach to assessment and treatment. Neurodegener Dis Manag. 2013;3(2):133-46.
  • 46. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308-14.
  • 47. Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000;12(2):233-9.
  • 48. Kertesz A, Nadkarni N, Davidson W, Thomas AW. The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia. J Int Neuropsychol Soc. 2000;6(4):460-8.
  • 49. Kertesz A, Davidson W, Fox H. Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia. Can J Neurol Sci. 1997;24(1):29-36.
  • 50. Wedderburn C, Wear H, Brown J, Mason SJ, Barker RA, Hodges J, et al. The utility of the Cambridge Behavioural Inventory in neurodegenerative disease. J Neurol Neurosurg Psychiatry. 2008;79(5):500-3.
  • 51. Wear H, Wedderburn C, Mioshi E, Williams-Gray C, Mason S, Barker R, et al. The Cambridge behavioural inventory revised. Dement Neuropsychol. 2008;2(2):102-10.
  • 52. Rohrer JD, Nicholas JM, Cash DM, van Swieten J, Dopper E, Jiskoot L, et al. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. Lancet Neurol. 2015;14(3):253-62.
  • 53. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, et al. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology. 1989;39(9):1159-65.
  • 54. Stern Y, Mayeux R, Sano M, Hauser WA, Bush T. Predictors of disease course in patients with probable Alzheimer’s disease. Neurology. 1987;37:1649.
  • 55. Blazer DG. The psychiatric interview of older adults. In: Blazer DG, Steffens DC, editors. The American psychiatric publishing textbook of geriatric psychiatry. Washington, DC: American Psychiatric Publishing Inc; 2009. p. 187-99.
  • 56. Waldemar G, Dubois B, Emre M, Scheltens P, Tariska P, Rossor M. Diagnosis and management of Alzheimer’s disease and other disorders associated with dementia. The role of neurologists in Europe. European Federation of Neurological Societies. Eur J Neurol. 2000;7(2):133-44.
  • 57. Erkinjuntti T, Hokkanen L, Sulkava R, Palo J. The blessed dementia scale as a screening test for dementia. Int J Geriatr Psychiatry. 1988;3(4):267-73.
  • 58. Konstantinopoulou E, Aretouli E, Ioannidis P, Karacostas D, Kosmidis MH. Behavioral disturbances differentiate frontotemporal lobar degeneration subtypes and Alzheimer’s disease: evidence from the Frontal Behavioral Inventory. Int J Geriatr Psychiatry. 2013;28(9):939-46.
  • 59. Tsai RM, Boxer AL. Treatment of frontotemporal dementia. Curr Treat Options Neurol. 2014;16(11):319.
  • 60. Huey ED, Putnam KT, Grafman J. A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia. Neurology. 2006;66(1):17-22.
  • 61. Moretti R, Torre P, Antonello RM, Cattaruzza T, Cazzato G, Bava A. Rivastigmine in frontotemporal dementia: an open-label study. Drugs Aging. 2004;21(14):931-7.
  • 62. Mendez MF, Shapira JS, McMurtray A, Licht E. Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia. Am J Geriatr Psychiatry. 2007;15(1):84-7.
  • 63. Lampl Y, Sadeh M, Lorberboym M. Efficacy of acetylcholinesterase inhibitors in frontotemporal dementia. Ann Pharmacother. 2004;38(11):1967-8.
  • 64. Kertesz A, Morlog D, Light M, Blair M, Davidson W, Jesso S, Brashear R. Galantamine in frontotemporal dementia and primary progressive aphasia. Dement Geriatr Cogn Disord. 2008;25(2):178-85.
  • 65. Warren JD, Rohrer JD, Rossor M. Clinical review. Frontotemporal dementia. BMJ. 2013;347:f4827.
  • 66. Deakin JB, Rahman S, Nestor PJ, Hodges JR, Sahakian BJ. Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial. Psychopharmacology (Berl). 2004;172(4):400-8.
  • 67. Mendez MF, Shapira JS, Miller BL. Stereotypical movements and frontotemporal dementia. Mov Disord. 2005;20(6):742-5.
  • 68. Lebert F, Stekke W, Hasenbroekx C, Pasquier F. Frontotemporal dementia: a randomised, controlled trial with trazodone. Dement Geriatr Cogn Disord. 2004;17(4):355-9.
  • 69. Ikeda M, Shigenobu K, Fukuhara R, Hokoishi K, Maki N, Nebu A, et al. Efficacy of fluvox- amine as a treatment for behavioral symptoms in frontotemporal lobar degeneration patients. Dement Geriatr Cogn Disord. 2004;17(3):117-21.
  • 70. Herrmann N, Black SE, Chow T, Cappell J, Tang-Wai DF, Lanctot KL. Serotonergic function and treatment of behavioral and psychological symptoms of frontotemporal dementia. Am J Geriatr Psychiatry. 2012;20(9):789-97.
  • 71. Adler G, Teufel M, Drach LM. Pharmacological treatment of frontotemporal dementia: treatment response to the MAO-A inhibitor moclobemide. Int J Geriatr Psychiatry. 2003;18(7):653-5.
  • 72. Manoochehri M, Huey ED. Diagnosis and management of behavioral issues in frontotemporal dementia. Curr Neurol Neurosci Rep. 2012;12(5):528-36.
  • 73. Riedl L, Mackenzie IR, Forstl H, Kurz A, Diehl-Schmid J. Frontotemporal lobar degeneration: current perspectives. Neuropsychiatr Dis Treat. 2014;10:297-310.
  • 74. Vugt ME, Stevens F, Aalten P, Lousberg R, Jaspers N, Winkens I, et al. Do caregiver management strategies influence patient behaviour in dementia? Int J Geriatr Psychiatry. 2004;19:85-92.
  • 75. Matsumoto N, Ikeda M, Fukuhara R, Shinagawa S, Ishikawa T, Mori T, et al. Caregiver burden associated with behavioral and psychological symptoms of dementia in elderly people in the local community. Dement Geriatr Cogn Disord. 2007;23:219-24.
  • 76. Melo G, Maroco J, De Mendonfa A. Influence of personality on caregiver’s burden, depression and distress related to the BPSD. Int J Geriatr Psychiatry. 2011;26(12):1275-82.
  • 77. Farrajota L, Maruta C, Maroco J, Martins IP, Guerreiro M, de Mendonfa A. Speech therapy in primary progressive aphasia: a pilot study. Dement Geriatr Cogn Dis Extra. 2012;2(1):321-31.

  • [1] Mesulam M. Primary progressive aphasia. Ann Neurol. 2001;49:425-32. 2. Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al.Classification of primary progressive aphasia and its variants. Neurology.2011;76(11):1006-14.
 
Source
< Prev   CONTENTS   Source   Next >